ArticleBMC ophthalmology2025
Seasonal Hyperacute Panuveitis from the highest reported altitude: co-occurrence with scleritis - an unusual presentation.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeSeasonal Hyperacute Panuveitis (SHAPU) is a severe, rapid-onset panuveitis primarily affecting children, often linked to the setae released in the air or by contact with female moths of the genus Gazalina (Lepidoptera, Notodontidae), or with their egg masses laid on various substrates. This study aims to report a rare case of SHAPU from the higher altitude of Nepal with an alpine climate, with concurrence of necrotising scleritis. To the best of our knowledge, this is the first report of SHAPU at high elevation. CASE REPORT: A 27-year-trekker male from an alpine climatic region of eastern Nepal was referred to our department, tertiary eye care in Nepal, with a history of sudden onset of redness, pain and decreased vision in his left eye following an indirect contact with a female Gazalina moth resting in his trekking bag during an ascent from 2,364 to 4,371 m above sea level. Circumcorneal congestion and cells, and flare were observed on clinical examination in the anterior chamber. A necrotising patch was present at the anterior sclera. The details of the lens, vitreous and retina were obscured because of hazy media. Ocular ultrasonography showed hyperechoic shadows in the vitreous with a thickening retina-choroid-sclera complex, suggestive of vitritis. He underwent treatment with antibiotics and steroids via all possible routes (topical, intraocular, periocular and systemic), and the scleral perforation could be prevented, but the visual rehabilitation was not possible.
conclusionSHAPU primarily affects the uveal tissue, but its spread of uveal inflammation to the scleral tissue must be borne in mind. This SHAPU case from a high altitude with intense ocular pain suggests new aspects of SHAPU's pathophysiology, contrasting with its typical painless presentation, warranting further research on the study moth's habitat at higher altitudes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.